Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:OPP NYSEARCA:PPHCRRD NYSEARCA:REMXCRRD NYSEARCA:XMPTCRRD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeOPPRiverNorth/DoubleLine Strategic Opportunity Fund$8.69-0.5%$8.48$7.91▼$9.30N/AN/A89,965 shs136,173 shsPPHCRRDVanEck Vectors Pharmaceutical ETF$0.00$0.00▼$0.00N/AN/AN/AN/AREMXCRRDVanEck Vectors Rare Earth/Strategic Metals ETF$0.00$0.00▼$0.00N/AN/AN/AN/AXMPTCRRDVanEck Vectors CEF Municipal Income ETF$0.00$0.00▼$0.00N/AN/AN/AN/A7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceOPPRiverNorth/DoubleLine Strategic Opportunity Fund0.00%+0.92%+2.10%+3.13%-2.09%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationOPPRiverNorth/DoubleLine Strategic Opportunity FundN/AN/AN/AN/AN/AN/AN/AN/APPHCRRDVanEck Vectors Pharmaceutical ETFN/AN/AN/AN/AN/AN/AN/AN/AREMXCRRDVanEck Vectors Rare Earth/Strategic Metals ETFN/AN/AN/AN/AN/AN/AN/AN/AXMPTCRRDVanEck Vectors CEF Municipal Income ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceOPPRiverNorth/DoubleLine Strategic Opportunity Fund 0.00N/AN/AN/APPHCRRDVanEck Vectors Pharmaceutical ETF 0.00N/AN/AN/AREMXCRRDVanEck Vectors Rare Earth/Strategic Metals ETF 0.00N/AN/AN/AXMPTCRRDVanEck Vectors CEF Municipal Income ETF 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookOPPRiverNorth/DoubleLine Strategic Opportunity Fund$25.48MN/AN/AN/AN/AN/APPHCRRDVanEck Vectors Pharmaceutical ETFN/AN/AN/AN/AN/AN/AREMXCRRDVanEck Vectors Rare Earth/Strategic Metals ETFN/AN/AN/AN/AN/AN/AXMPTCRRDVanEck Vectors CEF Municipal Income ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateOPPRiverNorth/DoubleLine Strategic Opportunity FundN/AN/A0.00∞N/AN/AN/AN/AN/APPHCRRDVanEck Vectors Pharmaceutical ETFN/AN/A0.00N/AN/AN/AN/AN/AN/AREMXCRRDVanEck Vectors Rare Earth/Strategic Metals ETFN/AN/A0.00N/AN/AN/AN/AN/AN/AXMPTCRRDVanEck Vectors CEF Municipal Income ETFN/AN/A0.00N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthOPPRiverNorth/DoubleLine Strategic Opportunity Fund$1.1613.34%N/AN/AN/APPHCRRDVanEck Vectors Pharmaceutical ETFN/AN/AN/AN/AN/AREMXCRRDVanEck Vectors Rare Earth/Strategic Metals ETFN/AN/AN/AN/AN/AXMPTCRRDVanEck Vectors CEF Municipal Income ETFN/AN/AN/AN/AN/ALatest REMXCRRD, XMPTCRRD, PPHCRRD, and OPP DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/7/2025OPPRiverNorth/DoubleLine Strategic Opportunity Fundmonthly$0.095013.3%9/15/20259/15/20259/30/20257/4/2025OPPRiverNorth/DoubleLine Strategic Opportunity Fundmonthly$0.095013.3%9/15/20259/15/20259/30/20257/3/2025OPPRiverNorth/DoubleLine Strategic Opportunity Fundmonthly$0.095013.3%9/15/20259/15/20259/30/20257/8/2025OPPRiverNorth/DoubleLine Strategic Opportunity Fund$0.095013.44%7/15/20257/16/20257/31/20255/13/2025OPPRiverNorth/DoubleLine Strategic Opportunity Fund$0.095013.45%5/15/20255/16/20255/30/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipOPPRiverNorth/DoubleLine Strategic Opportunity FundN/APPHCRRDVanEck Vectors Pharmaceutical ETFN/AREMXCRRDVanEck Vectors Rare Earth/Strategic Metals ETFN/AXMPTCRRDVanEck Vectors CEF Municipal Income ETFN/AInsider OwnershipCompanyInsider OwnershipOPPRiverNorth/DoubleLine Strategic Opportunity FundN/APPHCRRDVanEck Vectors Pharmaceutical ETFN/AREMXCRRDVanEck Vectors Rare Earth/Strategic Metals ETFN/AXMPTCRRDVanEck Vectors CEF Municipal Income ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableOPPRiverNorth/DoubleLine Strategic Opportunity FundN/AN/AN/ANot OptionablePPHCRRDVanEck Vectors Pharmaceutical ETFN/AN/AN/ANot OptionableREMXCRRDVanEck Vectors Rare Earth/Strategic Metals ETFN/AN/AN/ANot OptionableXMPTCRRDVanEck Vectors CEF Municipal Income ETFN/AN/AN/ANot OptionableREMXCRRD, XMPTCRRD, PPHCRRD, and OPP HeadlinesRecent News About These CompaniesNo headlines for this company have been tracked by MarketBeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeXMPTCRRD, OPP, REMXCRRD, and PPHCRRD Company DescriptionsRiverNorth/DoubleLine Strategic Opportunity Fund NYSE:OPP$8.69 -0.05 (-0.53%) Closing price 08/8/2025 03:59 PM EasternExtended Trading$8.69 0.00 (-0.05%) As of 08/8/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. is a closed ended fixed income mutual fund launched and managed by RiverNorth Capital Management, LLC. The fund is co-managed by DoubleLine Capital LP. It invests in fixed income markets. The fund seeks to benchmark the performance of its portfolio against the Barclays Capital U.S. Aggregate Bond Index. RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. was formed on December 30, 2010 and is domiciled in the United States.VanEck Vectors Pharmaceutical ETF NYSEARCA:PPHCRRDVanEck Vectors Rare Earth/Strategic Metals ETF NYSEARCA:REMXCRRDVanEck Vectors CEF Municipal Income ETF NYSEARCA:XMPTCRRD More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 08/04 - 08/08 Rocket Lab Reports Q2 Results: Is the Bull Thesis Still Intact? Airbnb Beats Earnings, But the Growth Story Is Losing Altitude Dutch Bros Just Flipped the Script With a Massive Earnings Beat Amazon Takes an Equity Stake in IonQ—Any Upside Potential? D-Wave Delivers Growth Shock—Investors Eye Quantum Future Is Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity? Constellation Energy’s Earnings Beat Signals a New Era Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
